| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Biotechnology (IBB) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Biotechnology sector is negative (overall -1.8, positive 2.1, negative -3.8) on 20251106. The forces of Market Risk Prefrence (-1.5), Valuation Sentiment (-1), Broad Market Trend (-0.8), and Price Level (-0.5) will drive down the price. The forces of Sector Price Trend (0.4), Option Speculation (0.75), and Sentiment towards Fundamentals (0.9) will drive up the price. The swing to downside will be significant considering the negative sentiment forces (-3.8). The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on IBB trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Market Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-06 | 0% | 0.4% | 158.43 | 79 | 0.08% | 0.25% | 0.4 | -1.8 | 0.9 | 8 |
| 2025-11-05 | 1% | 0.4% | 158.31 | 81 | 1.43% | 0.26% | 0.5 | -1.3 | 1.2 | 4.3 |
| 2025-11-04 | 0% | 0.3% | 156.08 | 63 | -0.88% | 0% | -0.8 | -2.1 | 1.2 | 7 |
| 2025-11-03 | 1% | 0.3% | 157.46 | 78 | -1.2% | 0.06% | 0.2 | -0.7 | 1.8 | 4.8 |
| 2025-11-02 | 0% | 0.3% | 1 | 2.8 | 2 | 0 | ||||
| 2025-11-01 | 0% | 0.4% | 1 | 2.8 | 2 | 0 | ||||
| 2025-10-31 | 1% | 0.4% | 159.38 | 98 | 1.32% | 0.38% | 1 | 2.8 | 2 | 4.5 |
| 2025-10-30 | 0% | 0.3% | 157.31 | 86 | 0.22% | 0.19% | 0.5 | 1.5 | 1.7 | 1 |
| 2025-10-29 | 0% | 0.3% | 156.97 | 86 | -0.44% | 0.26% | 0.7 | 3.8 | 1.9 | 0 |
| 2025-10-28 | 0% | 0.3% | 157.66 | 96 | 0.35% | 0.39% | 0.6 | 1.9 | 0.6 | 7.7 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| IBB Behaviors |
| ● Biotechnology (33%): The directional probability for IBB is 20% from last trading session on Wed. Nov 5, 2025. Both emotion level 7 is much higher than sentiment level 0.8 on Thu. Nov 6, 2025. Biotechnology (IBB) is attracting noticeable market attention on Thu. Nov 6, 2025. IBB is likely to move higher on any positive news, and recover from any dips of negative news. When the price move is against the technical setup, sentiment and emotion, it's a sign of trend reversal. |
| 1 (8) Stifel upgrades biotech stock on a narrative shift in Alzheimer’s treatment Stifel sees Biogen stock rallying nearly 32% from here. (https://www.cnbc.com/) Thu. Nov 6, 2025 | |
| 2 (8) China’s Richest Self-Made Woman Amasses $19.7 Billion Fortune Amid Biotech Boom Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big pharma players, giving her a wealth boost. (https://www.forbes.com/) Wed. Nov 5, 2025 | |
| 3 (5) Healthy Returns: What to know about Pfizer and Novo Nordisk’s bidding war over obesity biotech Metsera Pfizer and Novo Nordisk are in a takeover clash over the obesity biotech Metsera, while some House Republicans warm to extending tax credits. (https://www.cnbc.com/) Wed. Nov 5, 2025 | |
| 4 (-4) Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera. (https://www.cnbc.com/) Wed. Nov 5, 2025 | |
| 5 (8) Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development. (https://www.fool.com/) Wed. Nov 5, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA